Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP14 - Targeted Therapy - Clinically Focused
- Type: Posters (Featured)
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP14.10 - Efficacy and Safety of Selpercatinib (LOXO-292) in East Asian Patients with RET Fusion-Positive NSCLC
00:00 - 00:00 | Presenter: Herbert H Loong
- Abstract
Loading... -
+
FP14.13 - Molecular Characterisation and Clinical Outcomes in RET Rearranged Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Aaron C Tan
- Abstract
Loading...
-
+
P37 - Pathology - Biomarker Testing
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 34
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P37.18 - Lung NSCLC Molecular Diagnostic Comparison Between NGS and Multiplex PCR Assays
00:00 - 00:00 | Presenter: Kiat Hon Tony Lim
- Abstract
Loading...
-
+
P38 - Pathology - Pathology/Staging
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 19
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P38.03 - Immunohistochemical, Histologic and Genomic Characterisation of Early Stage Pulmonary Invasive Mucinous Adenocarcinoma
00:00 - 00:00 | Presenter: Aaron C Tan
- Abstract
Loading...
-
+
P59 - Tumor Biology and Systems Biology - Basic and Translational Science - Genomics
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 8
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P59.08 - THOR: Multi-Ethnic, Open Access Thoracic Cancer Genomics Resource
00:00 - 00:00 | Author(s): Jacob J.S. Alvarez
- Abstract
Loading...
-
+
P69 - Tumor Biology and Systems Biology - Basic and Translational Science - RTK/EGFR
- Type: Posters
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 5
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P69.05 - Molecular and Cellular Heterogeneity Underpin Treatment Response Across a Spectrum of EGFR-Mutant Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Ju Yuan
- Abstract
Loading...
-
+
P76 - Targeted Therapy - Clinically Focused - EGFR
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 98
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P76.03 - Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Enriqueta Felip
- Abstract
Loading... -
+
P76.46 - First-Line Osimertinib in Asian Patients with Advanced EGFR-Mutant Lung Cancer
00:00 - 00:00 | Presenter: Wan-Ling Tan
- Abstract
Loading... -
+
P76.88 - Real-World Data of Osimertinib in Patients with Metastatic EGFRm+ NSCLC who Progressed on First-Line EGFR TKIs
00:00 - 00:00 | Presenter: Jun Ma
- Abstract
Loading...
-
+
PL01 - Opening Plenary Session (Japanese, Mandarin, Spanish Translation Available)
- Type: Plenary
- Track: N.A.
- Presentations: 9
- Coordinates: 1/28/2021, 18:00 - 20:00, Scientific Program Auditorium
-
+
PL01.02 - Chair
18:05 - 18:10 | Presenter: Daniel SW Tan
- Abstract
No abstract available for this presentation
-
+
OA01 - Established Drugs in Special Populations and New Drugs in Established Populations
- Type: Oral
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 9
- Coordinates: 1/29/2021, 09:15 - 10:15, Scientific Program Auditorium
-
+
OA01.06 - Randomised Phase 2 Study of Nivolumab (N) Versus Nivolumab and Ipilimumab (NI) Combination in EGFR Mutant NSCLC
09:40 - 09:50 | Presenter: Gillianne Geet Yi Lai
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA05 - Value and Quality in Lung Cancer
- Type: Oral
- Track: Health Services Research/Health Economics
- Presentations: 8
- Coordinates: 1/29/2021, 15:30 - 16:30, Scientific Program Auditorium
-
+
OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study
15:30 - 15:40 | Presenter: Abdul Rahman Jazieh
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA04 - Health Policy and the Real World
- Type: Mini Oral
- Track: Health Services Research/Health Economics
- Presentations: 10
- Coordinates: 1/29/2021, 16:45 - 17:45, Scientific Program Auditorium
-
+
MA04.06 - Clinical Characteristics and Outcomes in Advanced KRAS Mutant NSCLC – A Multi-Centre Collaboration in Asia (ATORG-005)
17:15 - 17:20 | Presenter: Jiyun Lee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
